Zeke Capital Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Zeke Capital Advisors’s Portfolio EIGR Stock Details EIGR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$15.3K	Sell
2022 Q3	$267K	Hold
2022 Q2	$224K	Hold
2022 Q1	$295K	Hold
2021 Q4	$184K	Hold
2021 Q3	$237K	Hold
2021 Q2	$302K	Buy
2021 Q1	$292K	Hold
2020 Q4	$406K	Hold
2020 Q3	$269K	Buy